Ocrelizumab dose selection for treatment of paediatric relapsing-remitting multiple sclerosis: Updated preliminary pharmacokinetic, safety and efficacy results from the OPERETTA 1 study
MULTIPLE SCLEROSIS JOURNAL(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要